| Product Code: ETC6736503 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decline in the growth rate of antiviral imports to China in 2024, the market remained concentrated with the top exporting countries being Puerto Rico, Metropolitan France, Germany, Spain, and Italy. The negative CAGR from 2020 to 2024 indicates a challenging market environment, while the significant drop in growth rate from 2023 to 2024 suggests a potential shift in dynamics. Keeping an eye on these trends and understanding the strategies of key exporters will be crucial for stakeholders in the antivirals market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Antivirals Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 China Antivirals Market - Industry Life Cycle |
3.4 China Antivirals Market - Porter's Five Forces |
3.5 China Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 China Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral diseases in China |
4.2.2 Growing awareness about the importance of antivirals in healthcare |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for antiviral drugs in China |
4.3.2 High cost associated with research and development of antiviral medications |
4.3.3 Competition from alternative treatment options such as traditional Chinese medicine |
5 China Antivirals Market Trends |
6 China Antivirals Market, By Types |
6.1 China Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 China Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 China Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 China Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 China Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 China Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 China Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 China Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 China Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 China Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 China Antivirals Market Import-Export Trade Statistics |
7.1 China Antivirals Market Export to Major Countries |
7.2 China Antivirals Market Imports from Major Countries |
8 China Antivirals Market Key Performance Indicators |
8.1 Number of clinical trials for antiviral drugs conducted in China |
8.2 Investment in research and development of new antiviral treatments |
8.3 Adoption rate of antiviral medications in different regions of China |
9 China Antivirals Market - Opportunity Assessment |
9.1 China Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 China Antivirals Market - Competitive Landscape |
10.1 China Antivirals Market Revenue Share, By Companies, 2024 |
10.2 China Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |